drug

florbetaben f 18

1 story · latest Aug 6, 2026

Status: FDA approved Mar 2014 · NDA204677
Brand: Neuraceq

Relationships

Developed by Lantheus Holdings, Inc.

Timeline

Lantheus posts Q2 2026 results, pulls guidance amid pending Curium merger

Aug 6Quarterly updateLantheus Holdings, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.